Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-15T02:27:34.329Z Has data issue: false hasContentIssue false

La variabilité du phénotype dans la dystrophie myotonique de Steinert

Published online by Cambridge University Press:  18 September 2015

Jean-Pierre Bouchard*
Affiliation:
Service de neurologie, Département des sciences neurologiques, Hôpital de l'Enfant-Jésus,, Québec
*
Département des sciences neurologiques, Hôpital de l'Enfant-Jésus, 1401 18è Rue, Québec, Québec, Canada G1J 1Z4
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Phenotype Variability in Myotonic Dystrophy Myotonic dystrophy, best known in the French literature as Steinert disease, is a dominantly inherited disorder. When the gene is fully expressed, it shows a characteristic clinical picture. Myopathy and myotonia are the main features, but this is a systemic disease which may involve many other organs such as the central nervous system, eyes, bones, endocrine system, etc. With the complete picture, physical and behavioral features make the diagnosis easy, only to be confirmed by neurological and ophthalmologic examination and/or electromyography. This work reviews the main clinical signs seen in the classical form of the disease. We also want to stress the variability of that picture. Finally, we describe a new dysmorphic sign in myotonic dystrophy: large prominent cupped auricles. Although not recognized, prominauris has been illustrated in a number of publications on myotonic dystrophy. Three of our adult male patients presenting the congenital form of the disease at birth have been investigated to rule out concomitant fragile-X syndrome. Both syndromes include mental retardation and dysmorphic ears. Our patients show the usual testicular atrophy, whereas the fragile-X syndrome includes testicular hypertrophy. Cytogenetic studies were normal. Old clinical description and new physical signs may lack prestige in the perspective of recent molecular biological breakthroughs, but to recognize the disease and help patients live with it will always be the role of practitioners.

Type
SPECIAL SUPPLEMENT Dystrophie myotonique au Québec
Copyright
Copyright © Canadian Neurological Sciences Federation 1989

References

RÉFÉRENCES

1.Batten, FE, Gibb, HP. Myotonia atrophica. Brain 1909; 32: 187205.CrossRefGoogle Scholar
2.Greenfield, JG. Notes on a family of ≪myotonia atrophica≫ and early cataract, with a report on an additional case of myotonia atrophica. Rev Neur Psych (Edin) 1911; 9: 169181.Google Scholar
3.Kennedy, F, Obendorf, CP. Myotonia atrophica, with a report of two cases. JAMA 1911; 57: 11171118.CrossRefGoogle Scholar
4.Harper, PS. Myotonic Dystrophy. In: ≪Major Problems in Neurology≫, vol. 9 Philadelphia: W B Saunders Co. 1979.Google Scholar
5.Merritt, HH. A Textbook of Neurology (Fourth edition). Philadephia: Lea & Febiger 1967.Google Scholar
6.Schotland, DL. Muscular Dystrophy. New York: Medcom 1971.Google Scholar
7.Brooke, MH. A Clinician’s View of Neuromuscular Diseases (Second edition). Baltimore: Williams & Wilkins 1986.Google Scholar
8.Hagerman, RH, McBogg, P. The Fragile X Syndrome. Dillon (Colorado): Spectra Publishing Co. 1983.CrossRefGoogle ScholarPubMed
9.Harper, PS. Myotonic disorders. In: Engel, AE, Banker, BQ, eds. Myology, vol. 2, chapter 40. New York: McGraw-Hill 1986.Google Scholar